Epcoritamab,rituximab,cyclophosphamide,doxorubicin,vincristine,prednisone,lenalidomide,bendamustine,cytarabine,dexamethasone,oxaliplatin,carboplatin,gemcitabine,ifosfamide
genmab,abbvie
['dlbcl', 'epco ', 'cml']
dlbcl ed session #17icml bispecifics:
- epco / glofi work at lower concentrations
- bispecific + adc combinations
- updates in oral sessions 
Hematologist MD, PhD @ClinicaNavarra @CancerCCUN @unav #lymphoma #CLL #CART #CardioOnc Opinions are my own